Nottingham consensus sets out a policy route for dementia prevention

A multidisciplinary panel in England has produced a structured policy framework for dementia risk reduction, reaching consensus on 56 recommendations across public health messaging, individual-level interventions, population-level interventions and research commissioning. The effort reflects a growing recognition that dementia prevention cannot rely on isolated clinical advice alone; it demands coordinated action across health services, public institutions and wider social policy.

The consensus process mattered because the scientific case for prevention is advancing faster than the policy machinery built to deliver it. Dementia remains a major public health burden, with global prevalence projected to nearly triple by 2050 and societal costs already enormous. Against that backdrop, the Nottingham panel aimed to convert epidemiologic evidence into language and priorities that policymakers can use now, rather than waiting for a definitive prevention trial that may take decades to complete.

One point ran through the entire exercise: prevention strategy must not widen existing inequalities.

A modified Delphi process grounded in clinical, policy and lived experience

The National Institute for Health and Care Research Policy Research Unit in Dementia and Neurodegeneration at Queen Mary University of London convened the panel, bringing together 40 experts from across England with academic, clinical, policy, advocacy and lived experience. The steering committee expanded the exercise through an in-person workshop and a three-round modified Delphi survey, a method well suited to areas where evidence is incomplete, competing priorities need to be reconciled, and agreement must be built transparently.

The panel’s composition was deliberately broad. It included people with lived experience, researchers, clinicians, policy experts and representatives from dementia charities, with attention to career stage, gender and ethnicity. That mix was not cosmetic. Prevention policy fails when it is written only from a biomedical vantage point and ignores the practical barriers faced by communities most exposed to deprivation, low access to services and lower health literacy.

Fifty-four potential panellists were invited between April and September 2024, and 41 agreed to participate in the workshop and/or online survey. The workshop took place on 3 and 4 October 2024 in Nottingham, followed by three rounds of online surveys between October and December 2024. Panellists rated statements on a five-point Likert scale, and consensus required combined agreement from at least 67% of respondents.

56 recommendations across four policy domains

The final output was not a generic call for “more awareness.” It was a set of 56 recommendations distributed across four domains: public health messaging, individual-level interventions, population-level interventions and research commissioning. Each domain reflects a different lever for changing dementia risk, from the way public information is framed to the structural conditions that shape exposure to modifiable risk factors across the life course.

The strongest common thread was equity. Panelists prioritized the need to consider and address health inequalities so that dementia prevention does not simply amplify advantages already concentrated in healthier, wealthier groups. In practical terms, that means prevention campaigns cannot assume equal access to information, digital resources, primary care follow-up or safe environments for physical activity. Risk reduction advice has little reach if the people who most need it are least able to act on it.

The policy logic is clear. Many recognized dementia risk factors accumulate over decades, and several are tied to social position rather than individual willpower alone. Education, deprivation, ethnicity and area-level disadvantage shape lifetime exposure to cardiometabolic risk, access to hearing care, smoking cessation, healthy food, clean air and timely diagnosis. A policy architecture that ignores those gradients will likely produce only modest and uneven gains.

Why the prevention evidence now demands policy translation

The article places the consensus work within a broader evidence base that has matured considerably in recent years. The 2024 Lancet Commission on Dementia Prevention, Intervention and Care identified 14 potentially modifiable risk factors, spanning early, midlife and later life. Taken together, those factors are estimated to account for up to 45% of global dementia risk. Smoking cessation, blood pressure control, treatment of hearing loss, physical activity, diabetes management, limiting alcohol exposure and reducing social isolation all sit within that framework.

But there is a gap between identifying modifiable risk and proving how to change it at scale. Dementia has a long prodromal phase, risk factors often begin decades before symptoms, and direct prevention trials face formidable logistical barriers: long follow-up, low event rates and very large sample sizes. Many existing studies focus on intermediate outcomes such as cognition rather than incident dementia, which limits their policy impact even when findings are encouraging.

This is why the Nottingham consensus matters. It does not claim to solve the trial evidence problem. It provides a policymaking bridge for a condition in which waiting for perfect causal certainty would mean inaction.

Public messaging, clinical action and system-level responsibility

The consensus also reflects a shift away from the outdated idea that dementia prevention belongs only to specialty memory clinics. Public health messaging has a role, but messaging alone is insufficient. Clinicians still matter in identifying and managing hearing loss, hypertension, diabetes, depression, obesity and smoking, yet the burden of implementation cannot rest only with front-line consultations.

Population-level intervention is where the policy gains can become durable. Environmental design, air quality, access to education, social connection and healthier commercial conditions shape risk long before a patient enters a clinic. Because age-specific dementia incidence appears to have declined in some high-income countries over the past 30 years, partly through public health and behavioral changes, the panel’s recommendations sit on a plausible historical foundation rather than on abstract theory.

The article also acknowledges a sharper reality: reductions in dementia incidence have not been evenly distributed. One cited study found that incidence declines in the UK occurred exclusively in the wealthiest third of the population. A prevention policy that reaches only those already best positioned to benefit would be a failure of both science and justice.

What the Delphi process can and cannot settle

The methods were rigorous for a consensus exercise. The study used a prospectively registered protocol, followed ACCORD reporting guidelines, embedded patient and public involvement throughout and refined statements iteratively after each survey round. Agreement thresholds were explicit, and statements that reached consensus were graded further using a standard Delphi classification system.

Even so, consensus is not the same as proof of effectiveness. The recommendations represent a reasoned policy synthesis from experts with varied backgrounds, not an outcome trial showing reduced dementia incidence. The article is honest about that boundary, and the boundary is important. Policy guidance can organize action, but implementation still needs evaluation, funding and political commitment.

The next step is not scientific abstraction. It is adoption, adaptation and sustained cross-sector advocacy. The recommendations were developed for England, yet the framework is broad enough to inform other settings, including countries with fewer resources where priorities will need to be reordered around local feasibility and existing prevention infrastructure.

For dementia prevention, the central challenge remains unchanged: turning known risk factors into fair, workable public policy before the burden rises further.

A policy framework with unfinished work ahead

The consensus gives England a usable starting point, but the article leaves several practical questions open. Which recommendations will be funded first, how they will be monitored, and how success will be measured across deprived and underserved populations are still unresolved. Without those answers, the gap between agreed language and effective prevention will remain substantial.


Reporting by Dr. David Thorne, MD, FAAN for Medicine World Foundation, with additional data provided by Nature Reviews Neurology.